Language: English
Published by Nova Science Pub Inc, 2011
ISBN 10: 1612093949 ISBN 13: 9781612093949
Seller: Ammareal, Morangis, France
£ 4.88
Quantity: 1 available
Add to basketHardcover. Condition: Très bon. Ancien livre de bibliothèque. Edition 2011. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Edition 2011. Ammareal gives back up to 15% of this item's net price to charity organizations.
Language: English
Published by Nova Science Pub Inc, 2012
ISBN 10: 1612093949 ISBN 13: 9781612093949
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Language: English
Published by Nova Science Pub Inc, 2012
ISBN 10: 1612093949 ISBN 13: 9781612093949
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Language: English
Published by Nova Science Pub Inc, 2012
ISBN 10: 1612093949 ISBN 13: 9781612093949
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Language: English
Published by Nova Science Pub Inc, 2012
ISBN 10: 1612093949 ISBN 13: 9781612093949
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: As New. Unread book in perfect condition.
Language: English
Published by Nova Science Publishers Inc, 2012
ISBN 10: 1612093949 ISBN 13: 9781612093949
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Hardback. Condition: New. New copy - Usually dispatched within 4 working days.
Language: English
Published by Nova Science Publishers Inc Aug 2011, 2011
ISBN 10: 1612093949 ISBN 13: 9781612093949
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Neuware - As the scope of available drug therapies expands, spending on prescription drugs has become the fastest-growing category of total spending on health care in the United States. Recently, that growth has slowed and that slowdown reflects changes in both the supply and demand for prescription drugs. This book examines the innovation, development and complexity issues present in the pharmaceutical industry.